A new protocol for ovarian carcinoma

We are presenting the actual protocol for ovarian epithelial carcinoma and we want to emphasize that a surgical procedure must be necessary, in almost all cases, with a double objective: one, staging accuracy of tumor spread and two, surgical treatment in its different modalities. Chemotherapy as adjuvant therapy becomes a primary treatment even in early stages. New drugs such as CDDP, Hexametilmelanine and epirubicin, associated in different proportions have improved the overall survival in ovarian cancer. Nevertheless there is a very good series in the response, when external radiotherapy to the total pelvis or to the total abdomen, is indicated. The best benefit in overall survival was obtained in stages III and IV when a combination of surgery, polychemotherapy including CDDP and irradiation was indicated. There is united agreement that the factor that influences decisively in survival is the size of the residual mass, and that independently of the indicated treatment. We must adjust the best type of surgery in order to remove the tumor mass localized in different areas. We think that this point is mandatory in order to get a good response with the adjuvant therapy association.